{"id":504240,"date":"2020-08-26T13:20:02","date_gmt":"2020-08-26T13:20:02","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=504240"},"modified":"2020-08-26T13:20:02","modified_gmt":"2020-08-26T13:20:02","slug":"contact-dermatitis-epidemiology-forecast-till-2030","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/contact-dermatitis-epidemiology-forecast-till-2030_504240.html","title":{"rendered":"Contact Dermatitis Epidemiology Forecast till 2030"},"content":{"rendered":"<div style=\"float:right; width:250px; padding:8px 10px 10px 10px;\"><a href=\"https:\/\/www.abnewswire.com\/uploads\/1585648587.jpeg\" style=\"border:none !important;\" target=\"_blank\" rel=\"nofollow\" ><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\"Contact Dermatitis Epidemiology Forecast till 2030\" src=\"https:\/\/www.abnewswire.com\/uploads\/1585648587.jpeg\" alt=\"Contact Dermatitis Epidemiology Forecast till 2030\" width=\"225\" height=\"225\" style=\"padding:0px 0px 10px 10px; border:0 solid !important;\" \/><\/a><\/p>\n<div class=\"quotes\">\n<div>DelveInsight Business Research LLP      <\/div>\n<\/div>\n<\/div>\n<div style=\"font-style:italic; padding:8px 0px;\">DelveInsight&#8217;s  &#8216;Contact Dermatitis &#8211; Epidemiology Forecast to 2030&#8217; report delivers an in-depth understanding of the disease, historical and forecasted Contact Dermatitis epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.<\/p>\n<\/div>\n<p style=\"text-align: justify;\">Contact Dermatitis (CD) is a type of eczema triggered by contact with a particular substance in the environment that the person is allergic to; it may react by causing the skin to itch and become red.<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Contact Dermatitis Epidemiology Perspective by DelveInsight<\/strong><\/p>\n<p style=\"text-align: justify;\">The <a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/contact-dermatitis-epidemiology-forecast\" target=\"_blank\"><strong>Contact Dermatitis&nbsp;epidemiology<\/strong><\/a> division provides insights about historical and current patient pool and forecasted trend for every seven major countries. The Contact Dermatitis epidemiology data are studied through all possible division to give a better understanding of the Disease scenario in 7MM. The Contact Dermatitis epidemiology segment covers the epidemiology data in the US, EU5 countries (Germany, Spain, Italy, France, and the UK), and Japan from 2017 to 2030. It also helps to recognize the causes of current and forecasted trends by exploring numerous studies, survey reports and views of key opinion leaders.<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/contact-dermatitis-epidemiology-forecast\" target=\"_blank\"><strong>Contact Dermatitis&nbsp;Epidemiology Segmentation in 7MM from 2017 to 2030<\/strong><\/a><\/p>\n<ul style=\"text-align: justify;\">\n<li>Total Diagnosed Prevalent Population of Contact Dermatitis<\/li>\n<li>Type-specific Diagnosed Prevalent Population of Contact Dermatitis Based on Clinical and Biological Evolution<\/li>\n<li>Gender-specific Diagnosed Prevalent Population of Contact Dermatitis<\/li>\n<li>Age-specific Diagnosed Prevalent Population of Contact Dermatitis<\/li>\n<li>Type-specific Diagnosed Prevalent Population of Contact Dermatitis<\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><strong><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/contact-dermatitis-epidemiology-forecast\" target=\"_blank\">Contact Dermatitis&nbsp;Epidemiology Insights<\/a><\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>The total diagnosed prevalent population of CD in 7 MM in 2017 was 43,359,201 &nbsp;<\/li>\n<li>The diagnosed prevalence of CD in geographies in 2017:-&nbsp;<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">The United States- 13,786,942<\/p>\n<p style=\"text-align: justify;\">Germany &#8211; 6,645,210<\/p>\n<p style=\"text-align: justify;\">France &#8211; 5,481,080<\/p>\n<p style=\"text-align: justify;\">Spain &#8211; 1,982,709<\/p>\n<p style=\"text-align: justify;\">Japan- 5,107,575<\/p>\n<ul style=\"text-align: justify;\">\n<li>Gender-specific Diagnosed Prevalent Population of Contact Dermatitis in the United States in 2017&nbsp;<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">Males &#8211; 4,825,430<\/p>\n<p style=\"text-align: justify;\">Females &#8211; 8,961,513<\/p>\n<ul style=\"text-align: justify;\">\n<li>The type-specific diagnosed prevalent population of CD in the United States in 2017<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">11,029,554 &#8211; Irritant Contact Dermatitis (ICD) type<\/p>\n<p style=\"text-align: justify;\">2,757,388 &#8211; Allergic Contact Dermatitis (ACD) type<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Scope of the Report<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>The Contact Dermatitis report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns<\/li>\n<li>The Contact Dermatitis Epidemiology Report and Model provide an overview of the risk factors and global trends of Contact Dermatitis in the seven major markets (7MM:US, France, Germany, Italy, Spain, UK, and Japan)<\/li>\n<li>The report provides insight about the historical and forecasted patient pool of Contact Dermatitis in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan<\/li>\n<li>The report helps to recognize the growth opportunities in the 7MM with respect to the patient population<\/li>\n<li>The report assesses the disease risk and burden and highlights the unmet needs of Contact Dermatitis<\/li>\n<li>The report provides the segmentation of the Contact Dermatitis epidemiology<\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/contact-dermatitis-epidemiology-forecast\" target=\"_blank\"><strong>Request for sample pages<\/strong><\/a><br \/> <a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/contact-dermatitis-epidemiology-forecast\" target=\"_blank\"><strong>Table of contents<\/strong><\/a><\/p>\n<p style=\"text-align: justify;\">1.&nbsp;Key Insights&nbsp;<\/p>\n<p style=\"text-align: justify;\">2. Executive Summary of Contact Dermatitis<\/p>\n<p style=\"text-align: justify;\">3.&nbsp;Contact Dermatitis: Disease Background and Overview<\/p>\n<p style=\"text-align: justify;\">4.&nbsp;Patient Journey<\/p>\n<p style=\"text-align: justify;\">5.&nbsp;Epidemiology and Patient Population<\/p>\n<p style=\"text-align: justify;\">5.1.&nbsp;Epidemiology Key Findings<\/p>\n<p style=\"text-align: justify;\">5.2.&nbsp;Assumptions and Rationale: 7MM<\/p>\n<p style=\"text-align: justify;\">5.3.&nbsp;Epidemiology Scenario: 7MM<\/p>\n<p style=\"text-align: justify;\">5.4.&nbsp;United States Epidemiology<\/p>\n<p style=\"text-align: justify;\">5.5.&nbsp;EU-5 Country-wise Epidemiology<\/p>\n<p style=\"text-align: justify;\">5.5.1. Germany Epidemiology<\/p>\n<p style=\"text-align: justify;\">5.5.2. France Epidemiology<\/p>\n<p style=\"text-align: justify;\">5.5.3. Italy Epidemiology<\/p>\n<p style=\"text-align: justify;\">5.5.4. Spain Epidemiology<\/p>\n<p style=\"text-align: justify;\">5.5.5. United Kingdom Epidemiology<\/p>\n<p style=\"text-align: justify;\">5.6. Japan Epidemiology<\/p>\n<p style=\"text-align: justify;\">6.&nbsp;Treatment Algorithm, Current Treatment, and Medical Practices<\/p>\n<p style=\"text-align: justify;\">7.&nbsp;KOL Views<\/p>\n<p style=\"text-align: justify;\">8.&nbsp;Unmet Needs<\/p>\n<p style=\"text-align: justify;\">9.&nbsp;&nbsp;Appendix<\/p>\n<p style=\"text-align: justify;\">10.&nbsp;DelveInsight Capabilities<\/p>\n<p style=\"text-align: justify;\">11.&nbsp;Disclaimer<\/p>\n<p style=\"text-align: justify;\">12.&nbsp;About DelveInsight<\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/companyname\/delveinsight.com_56407.html\" rel=\"nofollow\">DelveInsight<\/a><br \/><strong>Contact Person:<\/strong> Priya Maurya<br \/><strong>Email:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/email_contact_us.php?pr=contact-dermatitis-epidemiology-forecast-till-2030\" rel=\"nofollow\">Send Email<\/a><br \/><strong>Phone:<\/strong> +919650213330<br \/><strong>City:<\/strong> Albany<br \/><strong>State:<\/strong> New York<br \/><strong>Country:<\/strong> United States<br \/><strong>Website:<\/strong> <a href=\"https:\/\/www.delveinsight.com\/\" target=\"_blank\" rel=\"nofollow\">https:\/\/www.delveinsight.com\/<\/a><\/p>\n<p><object type=\"text\/html\" data=\"https:\/\/www.delveinsight.com\/\" style=\"width:900px; height:400px;\"><\/object><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=contact-dermatitis-epidemiology-forecast-till-2030\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>DelveInsight Business Research LLP DelveInsight&#8217;s &#8216;Contact Dermatitis &#8211; Epidemiology Forecast to 2030&#8217; report delivers an in-depth understanding of the disease, historical and forecasted Contact Dermatitis epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/contact-dermatitis-epidemiology-forecast-till-2030_504240.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[406,423,420,403,404],"tags":[],"class_list":["post-504240","post","type-post","status-publish","format-standard","hentry","category-Pharmaceuticals-Biotech","category-Professional-Services","category-Science","category-UK","category-US"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/504240","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=504240"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/504240\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=504240"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=504240"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=504240"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}